Subfield · Pathology and Forensic Medicine
Most cited papers in Pathology and Forensic Medicine
What are the most cited papers in Pathology and Forensic Medicine?
The most cited paper in Pathology and Forensic Medicine is "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008" (Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al., 2010), with 21,446 citations. Next come "Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics" (19,316) and "Rating neurologic impairment in multiple sclerosis" (15,106).
Showing 50 of 100 papers. Every paper with more than 4,051 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer | 17 Jun 2010 | 21,446 |
| 2 | Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics Yoshinobu Kanda · Bone Marrow Transplantation | 3 Dec 2012 | 19,316 |
| 3 | Rating neurologic impairment in multiple sclerosis John F. Kurtzke · Neurology | Nov 1983 | 15,106 |
| 4 | The 1982 revised criteria for the classification of systemic lupus erythematosus Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism | Nov 1982 | 14,664 |
| 5 | The 2007 WHO Classification of Tumours of the Central Nervous System Hiroko Ohgaki, Otmar Dieter Wiestler, Webster K. Cavenee et al. · Digital Access to Scholarship at Harvard (DASH) (Harvard University) | 2007 | 14,012 |
| 6 | Vitamin D Deficiency Michael F. Holick · New England Journal of Medicine | 18 Jul 2007 | 13,754 |
| 7 | Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II JOHN B. DEC. M. SAUNDERS, Olaf Gjerløw Aasland, Thomas F. Babor et al. · Addiction | Jun 1993 | 13,467 |
| 8 | APACHE II-A Severity of Disease Classification System William A. Knaus, Elizabeth A. Draper, Douglas P. Wagner et al. · Critical Care Medicine | Aug 1986 | 13,426 |
| 9 | Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology | 2013 | 13,212 |
| 10 | A genetic model for colorectal tumorigenesis Eric R. Fearon, Bert Vogelstein · Cell | Jun 1990 | 12,218 |
| 11 | Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus Marc C. Hochberg · Arthritis & Rheumatism | Sep 1997 | 11,602 |
| 12 | Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif et al. · Hepatology | 28 Dec 2015 | 11,032 |
| 13 | Mutations of the BRAF gene in human cancer Helen Ruth Davies et al. · Nature | Jun 2002 | 10,791 |
| 14 | Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline Michael F. Holick, Neil Binkley, Heike Annette Bischoff-Ferrari et al. · The Journal of Clinical Endocrinology & Metabolism | 7 Jun 2011 | 10,622 |
| 15 | Signatures of mutational processes in human cancer Australian Pancreatic Cancer Genome Initiative et al. · Nature | 14 Aug 2013 | 10,284 |
| 16 | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Ash A. Alizadeh et al. · Nature | Feb 2000 | 10,021 |
| 17 | Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology | 11 Jan 2011 | 9,914 |
| 18 | The Cancer Genome Atlas Pan-Cancer analysis project John N. Weinstein, Eric A Collisson, Gordon Brent Mills et al. · Nature Genetics | 26 Sep 2013 | 9,847 |
| 19 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency Dung Thi Le et al. · New England Journal of Medicine | 30 May 2015 | 9,595 |
| 20 | Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples Richard Peto, M. C. Pike, P. Armitage et al. · British Journal of Cancer | 1977 | 8,414 |
| 21 | Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria Alan J. Thompson et al. · The Lancet Neurology | 21 Dec 2017 | 8,265 |
| 22 | Polyphenols: food sources and bioavailability Claudine Manach, Augustin Scalbert, Christine Morand et al. · American Journal of Clinical Nutrition | May 2004 | 8,154 |
| 23 | The 2016 revision of the World Health Organization classification of lymphoid neoplasms Steven H. Swerdlow, Elı́as Campo, Stefano Aldo Pileri et al. · Blood | 15 Mar 2016 | 7,935 |
| 24 | Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Charles E. Murry, Robert B. Jennings, K A Reimer · Circulation | Nov 1986 | 7,857 |
| 25 | TGF-β SIGNAL TRANSDUCTION Joan Massagué · Annual Review of Biochemistry | Jun 1998 | 7,585 |
| 26 | Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma Richard S. Finn et al. · New England Journal of Medicine | 13 May 2020 | 7,547 |
| 27 | New diagnostic criteria for multiple sclerosis: Guidelines for research protocols Charles M. Poser, Donald W. Paty, Labe C. Scheinberg et al. · Annals of Neurology | Mar 1983 | 7,423 |
| 28 | Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis Vincenzo Mazzaferro, Enrico Regalia, Roberto Doci et al. · New England Journal of Medicine | 14 Mar 1996 | 7,221 |
| 29 | Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis W. I. McDonald, Alistair Compston, Gilles Edan et al. · Annals of Neurology | 26 Jun 2001 | 6,993 |
| 30 | Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade Dung Thi Le et al. · Science | 27 Jul 2017 | 6,813 |
| 31 | Genetic Alterations during Colorectal-Tumor Development Bert Vogelstein, Eric R. Fearon, Stanley R. Hamilton et al. · New England Journal of Medicine | Sep 1988 | 6,787 |
| 32 | Comprehensive molecular characterization of gastric adenocarcinoma Adam Joel Bass et al. · Nature | 23 Jul 2014 | 6,680 |
| 33 | A Gene-Expression Signature as a Predictor of Survival in Breast Cancer Marc J. van de Vijver et al. · New England Journal of Medicine | 18 Dec 2002 | 6,562 |
| 34 | A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples Mary Ann K. Markwell, Suzanne M. Haas, LORAN L. BIEBER et al. · Analytical Biochemistry | Jun 1978 | 6,504 |
| 35 | A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer Soonmyung Paik, Steven Shak, Gong Tang et al. · New England Journal of Medicine | 10 Dec 2004 | 6,414 |
| 36 | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments] NL Harris, ES Jaffe, H Stein et al. · Blood | Sep 1994 | 6,356 |
| 37 | The AUDIT Alcohol Consumption Questions (AUDIT-C) An Effective Brief Screening Test for Problem Drinking Kristen Bush · Archives of Internal Medicine | 14 Sep 1998 | 6,306 |
| 38 | Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer Bernard Fisher, Stewart Anderson, John Bryant et al. · New England Journal of Medicine | 16 Oct 2002 | 6,293 |
| 39 | pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up C.W. Elston, Ian Ogilvie Ellis · Histopathology | Nov 1991 | 6,254 |
| 40 | The Fatigue Severity Scale Lauren Krupp · Archives of Neurology | Oct 1989 | 6,141 |
| 41 | Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma Sattva Swarup Neelapu et al. · New England Journal of Medicine | 10 Dec 2017 | 6,098 |
| 42 | Definition and classification of cancer cachexia: an international consensus Kenneth Fearon, Florian Strasser, Stefan D. Anker et al. · The Lancet Oncology | 5 Feb 2011 | 5,828 |
| 43 | Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Valery L. Feigin et al. · The Lancet Neurology | 14 Mar 2019 | 5,824 |
| 44 | The Oswestry Disability Index Jeremy C. T. Fairbank, Paul B. Pynsent · Spine | Nov 2000 | 5,809 |
| 45 | Mutational heterogeneity in cancer and the search for new cancer-associated genes Michael S. Lawrence et al. · Nature | 16 Jun 2013 | 5,797 |
| 46 | Evaluation of Diagnostic Criteria for Ankylosing Spondylitis Sjef van der Linden, Hans A. Valkenburg, A. Cats · Arthritis & Rheumatism | Apr 1984 | 5,762 |
| 47 | Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma Yuan Chang, Ethel Cesarman, Melissa S. Pessin et al. · Science | 16 Dec 1994 | 5,746 |
| 48 | Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification Bruce D. Cheson, Richard I. Fisher, Sally Fiona Barrington et al. · Journal of Clinical Oncology | 11 Aug 2014 | 5,725 |
| 49 | CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine | 24 Jan 2002 | 5,630 |
| 50 | Cisplatin in cancer therapy: Molecular mechanisms of action Shaloam R. Dasari, Paul Bernard Tchounwou · European Journal of Pharmacology | 21 Jul 2014 | 5,600 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.